Margit Jeschke, PhD Novartis

Margit is Global Head Analytical Development Cell and Gene Therapy at Novartis, and the Biopharmaceutical R&D line manager with 15+ years of leadership experience. She possesses broad knowledge of drug development of recombinant proteins (antibodies, vaccines, antibody-drug conjugates, growth factors, coagulation factors, enzymes) as well as advanced therapy products.

Dr. Jeschke is also a senior analytical expert with extensive management and regulatory experience and has experience leading a section of 100+ co-workers.

Her specialties are protein and cell characterization, process development, CMC documents incl. specifications for Phase I to BLA/MAA filing, method development & validation for biologics QC, plus due dilligence and quality oversight/QA audits.